rare-diseases Archives

015 — Myeloma Bispecific, Uveal Melanoma, HD Eylea, Huntington’s, Fibrodysplasia Ossificans Progressive, CHAPLE Disease

Post author:admin
Post published:August 21, 2023
Post category:multiple myeloma ophthalmology rare-diseases

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With…

008 — Lantidra, Ngenla, Roctavian, Rystiggo, Skyclarys, Atorvaliq

Post author:admin
Post published:July 3, 2023
Post category:cardiology diabetes-obesity neurology rare-diseases

Here is information on the latest US FDA approvals, the week of June 26 – June 30, 2023. Please subscribe, rate and review this podcast. Thank you! Lantidra® for Type…

007 — Talzenna, Elevidys, Jardiance, Litfulo, Blincyto, Vyvgart Hytrulo, Ultravist

Post author:admin
Post published:June 26, 2023
Post category:breast cancer dermatology diabetes-obesity genitourinary cancers lymphoma rare-diseases

Here is information on the latest US FDA approvals, the week of June 19 – June 23, 2023. Please subscribe, rate and review this podcast. Thank you!Talzenna® plus Xtandi® for…

006 — Columvi, Linzess, Recell, Bylvay, Eroxon

Post author:admin
Post published:June 19, 2023
Post category:dermatology gastroenterology lymphoma ob-gyn-reproductive rare-diseases

Here is information on the latest US FDA approvals, the week of June 12 – June 16, 2023. Please subscribe, rate and review this podcast. Thank you!Columvi® for DLBCLThe FDA has…

001 — Veozah, Rexulti, Opill, Elfabrio

Post author:admin
Post published:May 15, 2023
Post category:neurology ob-gyn-reproductive rare-diseases

Here is information on the latest US FDA approvals, the week of May 8- May 12, 2023. Please subscribe, rate and review. Thank you!Veozah (fezolinetant)The FDA has approved Veozah (fezolinetant).…